Philanthropy & Grantmaking
(T30)
ALLIANCE FOR CANCER GENE THERAPY INC
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$3.2M
Total Revenue
$2.5M
Total Expenses
$6.3M
Net Assets
2
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
94.8%
Fundraising Efficiency
0.0%
Operating Reserve
30.04x
Liability-to-Asset
21.1%
Revenue Diversification
68.1%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $3.2M | $2.5M | $6.3M | 94.8% | 2 |
| 2022 | $3.3M | $1.8M | N/A | — | 2 |
| 2021 | $1.7M | $2.6M | N/A | — | 1 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.